| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Is IP The Most Cost Effective Choice For Your Business Communication Applications? |
|
Main Subject - Is IP The Most Cost Effective Choice For Your Business Communication Applications?
Too often a business assumes that IP based solutions are the best choice to satisfy their communication requirements. Particulalrly with convergence issues. But....don't get According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product caught making a hasty decision. There are viable options...and factors to consider before making a final choice. One of the problems with convergence is protocol, starting wi ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in th IP. While we tend to think in terms of Internet and IP, there are alternatives. Dedicated circuits come to mind, followed by frame relay. One option that hasn't gotten much lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. exposure but may offer some real advantages is gigabit Ethernet via fiber optics. The fiber overcomes the distance limitations associated with Ethernet. Ethernet allows for lay here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe er 2 switching versus IP based routing. From a private network perspective, this may be an ideal way of lowering overheads and improving latency and jitter issues. The same ap d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro lies to other transports such as a private radio network. The IP headers are only one solution to source and destination, and are necessary only when joining the public Interne ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc t where IPv4 is the required protocol by agreement (not technical requirement). In 1985, the choice of protocol was still being debated, and Ethernet and Token Ring were still easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ighting for dominance. Moving out of IP opens up other opportunities for improved performance and efficiency in other applications besides voice. From a marketing perspective nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically , "cost effective" applies when taken in the context of the five currencies people use - time, money, security, knowledge, and prestige. Consumerism exists only because people and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ eal in all five currencies and products can find their "cost effective" niche. "Money is rarely the issue, but when money is the issue it is the only issue." Fiber to the hom ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e or fiber to the curb is a nice thought, and it is becoming more common in new developments here in the US. The economics of this are simple - installing fiber during initial ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a construction costs little more than material at that time, and the cost is buried in the price of the new home to be recouped over 30 years. For the carriers, once a fiber infr dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod structure is in place at no cost to them its easier to take advantage of it than not. Fiber trunks are routinely installed when major road arteries are reworked. Again, its the cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin economics of reinstalling copper versus installing fiber once the existing facility is compromised by road construction. Unfortunately, this approach will only get FTTH/FTTC tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen o new developments, For existing neighborhoods, conversion will occur when the providers are faced with a major rework due to natural disaster or infrastructure degradation due t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel to age. To count on fiber anytime soon in these areas would be foolish. It is possible today to get up to gigabit Ethernet paths between major metropolitan areas in the US, a ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust d to some parts of Japan and Europe, much the way dedicated circuits are ordered. Bandwidth on demand capabilities are available to scale up and down in near real time as neede y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products d. Running a long haul Ethernet backbone can be significantly easier and more effective than running a routed backbone or using the Internet as the backbone for many companies . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de This can include companies that in turn provide services to individual users such as telephony services. What I am suggesting is a review and selection based on what makes th elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e best business AND technical sense. Is IP the right choice for the telecommunications you are supporting? Step back and take a closer look at ALL your options before deciding tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:London's Business Travelers: Choose A Bed That's Close To Your Arrival And Departure Gates Cotton Voyage - Fibre 2 Fashion
|